NATIONAL BIOSAFETY MANAGEMENT AGENCY ACT

Section 23: Application of Import and Export Permit

2015Section 23 of 44Federal Republic of Nigeria

(1) Any person, institution or body who wishes to import, export, transit or otherwise carry out a contained field trial, multi-locational trial or commercial release of a genetically modified organism shall apply to the Director General of the Agency not less than 270 days to the date of import, export, transit or the commencement of such activity.
(2) Any application under subsection (1) of this section shall include:
(a) the information and data requirement that may be specified by the Agency in the regulations, guidelines, and policy documents;
(b) a risk assessment report indicating the potential risk, if any that the genetically modified organisms may pose to human health including food safety, biological diversity or the environment including the consequence of unintentional releases;
(c) the nature and identity of the genetically modified organisms involved in the activity being proposed to be carried out;
(d) information relating to any release of the genetically modified organisms in Nigeria or elsewhere;
(e) the nature and purpose of the activities including such activities as storage, transportation, production, culture and processing;
(f) destruction, disposal or usage of the genetically modified organisms in any way whatsoever;
(g) a management plan for remediation measures to be undertaken in the event of:
(i) any unintentional introduction into the environment of the genetically modified organisms from contained laboratory;
(ii) the escape or persistence in the environment of a genetically modified organisms from a confined field trial; and
(iii) any unintended consequence to the environment from the placing of genetically modified organisms in the market.
(h) the place where, and the purpose for which the genetically modified organisms or the product thereof is planned to be developed, used, kept, released or marketed including detailed instructions for use and a proposed labelling and packaging scheme in accordance with the First Schedule to this Act; and
(i) a declaration to the effect that the information provided to correct including where appropriate, the undertaking from the origination of such information affirming its accuracy and completeness.
(3) In all cases, the Agency shall set out requirements for each activity with genetically modified organisms to determine the level of potential risk posed by such category of activity in accordance with the second schedule to this Act.

Cite this section

Section 23, NATIONAL BIOSAFETY MANAGEMENT AGENCY ACT (2015).

https://repo.podus.ai/laws/national-biosafety-management-agency-act/section/23/